Agilon Health (NYSE:AGL) Shares Scheduled to Reverse Split on Tuesday, March 31st

Shares of Agilon Health, Inc. (NYSE:AGL) are set to reverse split on the morning of Tuesday, March 31st. The 1-25 reverse split was announced on Wednesday, March 18th. The number of shares owned by shareholders will be adjusted after the market closes on Monday, March 30th.

Agilon Health Price Performance

Shares of NYSE:AGL traded down $0.11 during trading on Thursday, reaching $0.48. 6,375,500 shares of the company’s stock traded hands, compared to its average volume of 6,935,547. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. Agilon Health has a fifty-two week low of $0.34 and a fifty-two week high of $6.08. The company has a 50-day simple moving average of $0.69 and a 200-day simple moving average of $0.80. The firm has a market cap of $199.14 million, a PE ratio of -0.51 and a beta of 0.11.

Agilon Health (NYSE:AGL) last released its quarterly earnings results on Wednesday, February 25th. The company reported ($0.46) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.19). The business had revenue of $1.57 billion during the quarter, compared to analyst estimates of $1.46 billion. Agilon Health had a negative return on equity of 120.82% and a negative net margin of 6.60%. As a group, analysts predict that Agilon Health will post -0.59 earnings per share for the current year.

Analysts Set New Price Targets

Several equities research analysts recently commented on the stock. Weiss Ratings reissued a “sell (e+)” rating on shares of Agilon Health in a report on Wednesday, January 21st. Royal Bank Of Canada raised shares of Agilon Health from a “hold” rating to a “moderate buy” rating in a report on Wednesday, December 3rd. Barclays cut their target price on shares of Agilon Health from $1.00 to $0.50 and set an “underweight” rating for the company in a research note on Friday, February 27th. Wells Fargo & Company upped their price target on shares of Agilon Health from $1.00 to $1.50 and gave the stock an “overweight” rating in a research report on Friday, February 27th. Finally, Citigroup decreased their price target on shares of Agilon Health from $0.85 to $0.75 and set a “neutral” rating on the stock in a research note on Tuesday, March 3rd. Three investment analysts have rated the stock with a Buy rating, eleven have given a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $2.18.

Institutional Trading of Agilon Health

Hedge funds have recently bought and sold shares of the business. AQR Capital Management LLC boosted its holdings in shares of Agilon Health by 243.3% during the 1st quarter. AQR Capital Management LLC now owns 501,440 shares of the company’s stock worth $2,171,000 after purchasing an additional 355,365 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in Agilon Health by 3.5% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 214,200 shares of the company’s stock worth $927,000 after buying an additional 7,209 shares in the last quarter. Dynamic Technology Lab Private Ltd boosted its stake in Agilon Health by 28.4% during the first quarter. Dynamic Technology Lab Private Ltd now owns 47,111 shares of the company’s stock worth $204,000 after buying an additional 10,424 shares during the last quarter. Goldman Sachs Group Inc. grew its holdings in Agilon Health by 6.6% in the 1st quarter. Goldman Sachs Group Inc. now owns 5,060,333 shares of the company’s stock valued at $21,911,000 after buying an additional 311,158 shares in the last quarter. Finally, Geode Capital Management LLC grew its holdings in Agilon Health by 2.6% in the 2nd quarter. Geode Capital Management LLC now owns 7,156,466 shares of the company’s stock valued at $16,462,000 after buying an additional 178,477 shares in the last quarter.

About Agilon Health

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.